Parameter
| Biomarker | CEA | Full name | Carcinoembryonic antigen | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Complex glycoprotein | Molecular Weight | ~180-200 kDa | Core Functional Dimensions | Aid in diagnosis and monitoring |
| Disease | Cholangiocarcinoma (CCA) | Disease Subtypes | / | ||
| Organ | Bile duct/Liver | Test Sample / Technology Platform | Serum (immunoassay, ELISA) | ||
| Pathobiological Mechanisms | Abnormal expression of tumor cells, involved in tumor invasion and metastasis; A variety of benign diseases and other tumors may also increase | ||||
| Clinical Availability Status | Commonly used in clinic (auxiliary diagnosis); Low sensitivity and specificity | ||||
| Notes and Dynamics | Combined detection with CA19-9 can improve the diagnostic efficiency and can be used to dynamically monitor disease progression | ||||